The genetic depletion of Smad3 and systemic treatment with anti-TGF-β antibody has been shown to protect mice from diet-induced obesity, insulin resistance, and hepatic steatosis [133,134]. Here, SMAD3 is linked to obesity due to melanocortin 4 receptor deficiency.